JP5818817B2 - がん予後診断アッセイ - Google Patents

がん予後診断アッセイ Download PDF

Info

Publication number
JP5818817B2
JP5818817B2 JP2012551687A JP2012551687A JP5818817B2 JP 5818817 B2 JP5818817 B2 JP 5818817B2 JP 2012551687 A JP2012551687 A JP 2012551687A JP 2012551687 A JP2012551687 A JP 2012551687A JP 5818817 B2 JP5818817 B2 JP 5818817B2
Authority
JP
Japan
Prior art keywords
flc
cancer
light chain
total
free
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2012551687A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013519082A (ja
JP2013519082A5 (enExample
Inventor
ブラッドウェル，アーサー
ミード，グラハム
Original Assignee
ザ バインディング サイト グループ リミテッド
ザ バインディング サイト グループ リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ザ バインディング サイト グループ リミテッド, ザ バインディング サイト グループ リミテッド filed Critical ザ バインディング サイト グループ リミテッド
Priority claimed from PCT/GB2011/050193 external-priority patent/WO2011095818A1/en
Publication of JP2013519082A publication Critical patent/JP2013519082A/ja
Publication of JP2013519082A5 publication Critical patent/JP2013519082A5/ja
Application granted granted Critical
Publication of JP5818817B2 publication Critical patent/JP5818817B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2012551687A 2010-02-05 2011-02-04 がん予後診断アッセイ Active JP5818817B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1001950.3 2010-02-05
GBGB1001950.3A GB201001950D0 (en) 2010-02-05 2010-02-05 Infection prognostic assay
PCT/GB2011/050193 WO2011095818A1 (en) 2010-02-05 2011-02-04 Cancer prognosis assay

Publications (3)

Publication Number Publication Date
JP2013519082A JP2013519082A (ja) 2013-05-23
JP2013519082A5 JP2013519082A5 (enExample) 2014-04-10
JP5818817B2 true JP5818817B2 (ja) 2015-11-18

Family

ID=42082582

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012551687A Active JP5818817B2 (ja) 2010-02-05 2011-02-04 がん予後診断アッセイ
JP2012551689A Active JP5818818B2 (ja) 2010-02-05 2011-02-04 感染症予後診断アッセイ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012551689A Active JP5818818B2 (ja) 2010-02-05 2011-02-04 感染症予後診断アッセイ

Country Status (6)

Country Link
US (2) US20130217030A1 (enExample)
EP (1) EP2531857B1 (enExample)
JP (2) JP5818817B2 (enExample)
CN (2) CN102859361B (enExample)
GB (1) GB201001950D0 (enExample)
WO (1) WO2011095820A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2519564A (en) * 2013-10-24 2015-04-29 Shared Band Ltd Multicast transmission over bonded broadband
WO2016016897A1 (en) * 2014-07-30 2016-02-04 Smadar Avigad Prognostic methods and systems of treatment for acute lymphoblastic leukemia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4792529A (en) * 1985-10-18 1988-12-20 University Of Rochester Immunoassay of free kappa light chains for the detection of multiple sclerosis
IT1216698B (it) * 1988-04-01 1990-03-08 New Scient Co Spa Metodo per la determinazione della presenza di catene leggere libere in campioni di urina, complesso di preparati per l'esecuzione del metodo, e relativo reagente.
EP0862584B1 (en) 1995-11-03 2004-12-22 The Binding Site Limited Production of antibodies
US6322788B1 (en) * 1998-08-20 2001-11-27 Stanley Arthur Kim Anti-bacterial antibodies and methods of use
US20040018576A1 (en) * 2002-07-24 2004-01-29 Dematteo Todd M. Bence Jones protein testing cassette
JP4438455B2 (ja) * 2004-03-04 2010-03-24 ヤマサ醤油株式会社 遊離ヒトイムノグロブリン軽鎖の測定法及びキット
WO2005116651A2 (en) * 2004-05-24 2005-12-08 Diasys Corporation Method and device for testing for bence-jones protein
AU2005304320A1 (en) * 2004-11-12 2006-05-18 Board Of Regents, The University Of Texas System Methods of treating hematological malignancies with nucleoside analog drugs
GB0501741D0 (en) * 2005-01-27 2005-03-02 Binding Site The Ltd Antibody
EP2267449B1 (en) * 2005-04-12 2014-01-08 Akira Matsumori Biomarker for diagnosing heart failure and the use thereof
JP2007292661A (ja) * 2006-04-26 2007-11-08 Akira Matsumori 活動性心筋炎の検出方法および検出試薬
GB0801609D0 (en) * 2008-01-29 2008-03-05 Binding Site The Ltd Hevylite diagnostic stain

Also Published As

Publication number Publication date
CN102859362B (zh) 2015-11-25
JP2013519083A (ja) 2013-05-23
GB201001950D0 (en) 2010-03-24
EP2531857B1 (en) 2017-01-18
JP2013519082A (ja) 2013-05-23
US20130149792A1 (en) 2013-06-13
JP5818818B2 (ja) 2015-11-18
US20130217030A1 (en) 2013-08-22
CN102859361B (zh) 2015-06-17
EP2531857A1 (en) 2012-12-12
CN102859361A (zh) 2013-01-02
WO2011095820A1 (en) 2011-08-11
CN102859362A (zh) 2013-01-02

Similar Documents

Publication Publication Date Title
CN102639999B (zh) 存活预后分析
US8592561B2 (en) Antibodies for detecting or monitoring a malignant plasma cell disease
JP2013521490A (ja) 腎臓予後予測アッセイ
JP6240099B2 (ja) 形質細胞関連疾患を特性決定するための方法
AU2017232081A1 (en) Acute kidney injury
JP2013522617A (ja) バイオマーカーとしてのｆｌｃ
JP5818817B2 (ja) がん予後診断アッセイ
EP2531854B1 (en) Cancer prognosis assay
JP2015508173A (ja) 遊離軽鎖生成の推定に関する補正方法
WO2013088126A1 (en) Assay

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140204

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140224

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20140918

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20141104

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150204

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150304

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150901

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150929

R150 Certificate of patent or registration of utility model

Ref document number: 5818817

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250